DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20150368

Can occupational exposure to antineoplastic drugs increase levels of an inflammatory trigger?

T. Kamalasundar, Padmaja Udaykumar, Prabin Shah

Abstract


Background: Antineoplastic drugs (AND) are known to cause collateral damage to normal cells by oxidative stress. This study was conducted to check for oxidative stress in occupational exposure to these drugs using advanced oxidation protein products (AOPP).

Methods: Cross-sectional comparison of serum AOPP levels of 33 nurses occupationally exposed and serum AOPP levels of 30 nurses not exposed using modified AOPP method.

Results: Serum AOPP levels were significantly increased (p<0.001) in the exposed group (16.66±3.31) compared to the unexposed group (12.87±2.62).

Conclusion: This study highlights oxidative stress in the form of protein oxidation occurring in nurses exposed to AND.


Keywords


Antineoplastic drugs, Nurses, Advanced oxidation protein products, Protein oxidation

Full Text:

PDF

References


Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65-74.

Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv. 2007;7(3):147-56.

Gómez-Oliván LM, Miranda-Mendoza GD, Cabrera-Galeana PA, Galar-Martínez M, Islas-Flores H, Juan-Reyes NS, et al. Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: a multicentric study. Oxid Med Cell Longev. 2014;2014:Article ID: 858604.

Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689(2):91-102.

Anderstam B, Ann-Christin BH, Valli A, Stenvinkel P, Lindholm B, Suliman ME. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta. 2008;393(2):114-8.

Mahboob M, Rahman MF, Rekhadevi PV, Sailaja N, Balasubramanyam A, Prabhakar PV, et al. Monitoring of oxidative stress in nurses occupationally exposed to antineoplastic drugs. Toxicol Int. 2012;19(1):20-4.

Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161(5):2524-32.

Yoshida J, Kosaka H, Tomioka K, Kumagai S. Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan. J Occup Health. 2006;48(6):517-22.

Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer J Clin. 2006;56(6):354-65.